eHealth Stock Rises 45% in a Week: Medicare Boom or AEP Magic?

Zacks
24 Dec 2024

Shares of eHealth, Inc. EHTH, an online health insurance marketplace operator, soared 45.1% last week after the company raised its 2024 guidance, citing robust performance during the Annual Enrollment Period (AEP). It witnessed substantial growth in Medicare applications and a record-high number of unassisted online submissions.

eHealth exceeded expectations in telephonic and online conversion rates and leveraged strong consumer demand for its omnichannel platform. The platform connects users to more than 180 health insurers, encompassing both national and regional providers.

eHealth, Inc. Price

eHealth, Inc. price | eHealth, Inc. Quote

Now, let’s focus on its revised guidance.

Total revenue for 2024 is projected to be in the range of $500-$520 million compared with the prior range of $470-$495 million. This surpasses the Zacks Consensus Estimate of $487.3 million and reflects growth from the 2023 figure of $452.9 million.

Adjusted EBITDA is now expected to be significantly higher, ranging within $40-$55 million compared with the earlier forecast of $7.5-$25 million. The company has also revised its GAAP net income expectations to a range of a $12 million loss to a $3 million profit, an improvement from the previous estimate of a $22-$36.5 million loss.

Operating cash outflow is now expected to fall within $5-$15 million in 2024, slightly higher than the previous guidance of $0 to $10 million. This reflects planned investments to support profitable Medicare enrollment growth in the fourth quarter.

The Zacks Consensus Estimate for 2024 loss per share is pegged at $1.56, indicating a 4.3% improvement from a year ago. The company missed earnings estimates in each of the past four quarters with an average negative surprise of 59.4%. This is depicted in the graph below.

eHealth, Inc. Price and EPS Surprise

eHealth, Inc. price-eps-surprise | eHealth, Inc. Quote

Zacks Rank & Key Picks

eHealth currently has a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader Finance space are Brown & Brown, Inc. BRO, Assurant, Inc. AIZ and CNO Financial Group, Inc. CNO, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Brown & Brown’s 2024 earnings is pegged at $3.74 per share, indicating 33.1% year-over-year growth. Over the past 60 days, BRO has witnessed one upward estimate revision against none in the opposite direction.

The Zacks Consensus Estimate for Assurant’s 2024 earnings is pegged at $15.38 per share, which witnessed three upward estimate revisions in the past 60 days against one opposite movement. Also, the consensus mark for AIZ’s revenues in 2024 suggests a 6% year-over-year rise.

The Zacks Consensus Estimate for CNO Financial’s 2024 bottom line indicates 20.7% year-over-year growth. Over the past 60 days, CNO has witnessed three upward estimate revisions against none in the opposite direction.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CNO Financial Group, Inc. (CNO) : Free Stock Analysis Report

Assurant, Inc. (AIZ) : Free Stock Analysis Report

Brown & Brown, Inc. (BRO) : Free Stock Analysis Report

eHealth, Inc. (EHTH) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10